TESTSAMMELVORRICHTUNG

Patent europeic · EP4209180 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4209180
Numer da la dumonda
EP22174533
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
20-05-2022
Publitgà
12-07-2023
Concedì
01-04-2026
La protecziun finescha il pli tard
19-05-2042
Proxima taxa annuala scadenta
31-05-2026
Classas IPC
A61B 10/02 (2006.01)
A61B 10/00 (2006.01)
A61B 5/15 (2006.01)
G01N 1/02 (2006.01)
A61F 13/38 (2006.01)
Prioritad
CN 202210024877 10.01.2022
US 202263300811 P 19.01.2022
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-04-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 01.04.2026

Partidas

Possessur

Zhejiang Orient Gene Biotech Co., Ltd

No. 3787, East Yangguang Avenue, Dipu Street, Anji Huzhou Zhejiang 313300, CN

Inventur

FANG, Jianqiu

Huzhou, 313300, CN

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.